MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Co-Diagnostics EBITDA per Share 2011-2026 | CODX
Annual EBITDA per Share Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36.9 | -38.3 | -1.41 | -0.82 | 1.61 | 1.49 | -0.348 | -0.486 | -0.412 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.61 | -38.3 | -8.39 |
Quarterly EBITDA per Share Co-Diagnostics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.97 | -0.18 | -0.23 | -0.26 | - | -0.32 | -0.24 | -0.33 | - | -0.29 | -0.4 | -0.33 | - | -0.2 | -0.11 | 0.3 | - | 0.48 | 0.41 | 0.36 | - | 0.43 | 0.53 | -0.05 | - | -0.09 | -0.08 | -0.08 | - | -0.13 | -0.11 | -0.1 | - | -0.15 | -0.07 | -0.06 | - | -0.04 | -0.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.53 | -3.97 | -0.178 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 201.02 | -1.01 % | $ 22.3 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 88.17 | -0.43 % | $ 4.12 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 18.54 | -0.75 % | $ 571 M | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 20.56 | -0.68 % | $ 596 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.65 | 3.12 % | $ 7.3 M | USA |
 |
Illumina
ILMN
|
6.95 | $ 164.39 | 2.12 % | $ 25.5 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-3.17 | $ 129.45 | -1.65 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 22.98 | 0.04 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
10.5 | $ 146.18 | - | $ 11.5 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
NeoGenomics
NEO
|
-0.62 | $ 11.09 | -0.54 % | $ 1.42 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.51 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
1.35 | $ 18.35 | -2.34 % | $ 411 M | USA |
 |
Natera
NTRA
|
-1.96 | $ 214.4 | 1.1 % | $ 29.3 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 103.97 | -0.53 % | $ 7.02 B | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 189.74 | 1.19 % | $ 9.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.37 | 4.2 % | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 467.9 | 0.12 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 142.32 | 0.96 % | $ 23.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.29 | -0.92 % | $ 397 M | USA |
 |
Personalis
PSNL
|
-0.87 | $ 9.8 | 2.19 % | $ 875 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.83 | 1.4 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 7.28 | 1.35 % | $ 304 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 79.83 | 4.81 % | $ 4.77 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.03 | -1.22 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 263.98 | -0.82 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 469.74 | 0.19 % | $ 177 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.64 | -1.51 % | $ 230 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.13 | 0.33 % | $ 1.98 B | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |